Ye LYU is a Senior Healthcare Analyst at Western Securities Co., Ltd since April 2022, specializing in equity research within the healthcare, biotech, medical instruments, and medical service sectors. Prior to this role, Ye served as a Senior Healthcare Analyst at CEBM Group, focusing on significant biotech and biopharma companies. Experience as an Energy and Chemical Researcher at Soochow Futures Co., Ltd involved futures research on crude oil and other fuels. Ye's academic background includes a PhD in Chemistry from Sorbonne Université and a Master's in Chemical Biology from Xiamen University, complemented by a Chartered Financial Analyst (CFA) designation. Ye has contributed to meaningful research projects and scientific publications throughout an extensive academic and professional career in both healthcare and chemistry.
Western Securities Co., Ltd
Western Securities Co., Ltd., which was founded and approved by the China Securities Regulatory Commission in January 2001, is a leading securities institution in northwest China with registered capital of 1billion RMB. We have 56 regional branches in Shaanxi, Beijing, Shanghai, Shenzhen, Shandong and Jiangsu to service our clients. Business branches and sub-branches in Shanghai working mainly on proprietary trading, client asset management and securities research and development. We offer a combination of securities brokerage, investment banking, asset management, securities research and securities financing and margin services to our clients. In addition, our subsidiary Western Futures Ltd., collaborating with our main business operations, provides independent services in the derivatives area. Our Sino-US joint venture with the Bank of New York Mellon (BNY Mellon), New York Mellon Western Asset Management Co., Ltd., will provide superior public and private fund management services to our clients.